
    
      The multicentric prospective trial is to evaluate the quality of life and psychological
      effects in patients with head and neck tumor treated by curative intent radiation therapy.
      The treatment consists in a conventionally fractionated Intensity Modulated Radiotherapy
      (IMRT) or until 2.2 Gy per fraction with a total dose of 50-66 Gy in post-operative setting
      and 66-72 Gy in radical setting.
    
  